Search Browse Earnings

Traws Pharma, Inc. — SlamSEC

Traws Pharma, Inc.

Nasdaq:TRAW

Pharmaceutical Preparations·NEWTOWN, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$226,000

+0.0% YoY

FY 2024

Adj. EBITDA

-$20.3M

-8974.3% margin

FY 2024

Net Income

-$18.9M

-8384.1% margin

FY 2024

EPS (Diluted)

-$22.57

FY 2024

Stock Price

$1.73

+9.1%

2026-03-10

52W Range

$0.97 – $3.27

P/E Ratio

-0.1x

Market Cap

$13.8M

Cash

$20.6M

FY 2023

Total Debt

—

Net Cash

$20.6M

FY 2024

Enterprise Value

-$6.7M

Debt / EBITDA

1.0x

FY 2024

EV / EBITDA

0.3x

Employees

17

FY 2024